- Home
- ZTR vs HUMA Comparison
ZTR vs HUMA Comparison
Compare ZTR & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTR
- HUMA
- Stock Information
- Founded
- ZTR 1988
- HUMA 2004
- Country
- ZTR Australia
- HUMA United States
- Employees
- ZTR N/A
- HUMA N/A
- Industry
- ZTR Investment Managers
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- ZTR Finance
- HUMA Health Care
- Exchange
- ZTR Nasdaq
- HUMA Nasdaq
- Market Cap
- ZTR 340.0M
- HUMA 367.6M
- IPO Year
- ZTR N/A
- HUMA N/A
- Fundamental
- Price
- ZTR $6.15
- HUMA $2.34
- Analyst Decision
- ZTR
- HUMA Strong Buy
- Analyst Count
- ZTR 0
- HUMA 7
- Target Price
- ZTR N/A
- HUMA $13.00
- AVG Volume (30 Days)
- ZTR 219.4K
- HUMA 3.4M
- Earning Date
- ZTR 01-01-0001
- HUMA 08-12-2025
- Dividend Yield
- ZTR 12.09%
- HUMA N/A
- EPS Growth
- ZTR N/A
- HUMA N/A
- EPS
- ZTR N/A
- HUMA N/A
- Revenue
- ZTR N/A
- HUMA $517,000.00
- Revenue This Year
- ZTR N/A
- HUMA N/A
- Revenue Next Year
- ZTR N/A
- HUMA $896.45
- P/E Ratio
- ZTR N/A
- HUMA N/A
- Revenue Growth
- ZTR N/A
- HUMA N/A
- 52 Week Low
- ZTR $4.50
- HUMA $1.15
- 52 Week High
- ZTR $6.60
- HUMA $9.79
- Technical
- Relative Strength Index (RSI)
- ZTR 49.14
- HUMA 50.49
- Support Level
- ZTR $6.15
- HUMA $2.13
- Resistance Level
- ZTR $6.17
- HUMA $2.80
- Average True Range (ATR)
- ZTR 0.06
- HUMA 0.18
- MACD
- ZTR -0.00
- HUMA 0.01
- Stochastic Oscillator
- ZTR 55.56
- HUMA 35.69
About ZTR Virtus Total Return Fund Inc.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.